medigraphic.com
Revista Médica Sinergia

2020, Number 04

<< Back Next >>

Revista Médica Sinergia 2020; 5 (04)

Takotsubo cardiomyopathy actualization

Campos QM, Molina CD, Núñez GA

Language: Spanish
References: 17
Page: 1-11
PDF size: 160.87 Kb.


ABSTRACT

Takotsubo syndrome is a cardiomyopathy induced by physical or emotional stress, characterized by being a ventricular apical dilation, which predominantly affects postmenopausal women, currently its precise pathophysiological mechanisms are still unknown. It was initially considered a benign condition; however, it is currently known to be associated with severe clinical complications, including death. This pathology can be indistinguishable from acute coronary syndrome due to the similarity in clinical manifestations, electrocardiographic and laboratory findings. Coronary angiography with ventriculography is considered the diagnostic method of choice. Currently there is no management guide, however, the treatment goal is based on support measures and addressing associated complications.


REFERENCES

  1. Monstes erín Matesanz C, Piñeiro Otero P, Gonzalez Benito E, López Martínez M, González Cantero JL. Sindrome de Takotsubo. A propósito de un caso. Rev Arg Anestesiol [internet]. 2017 [citado 22 de enero 2020]; 75 (2): 70-74. Disponible en: https://www.elsevier.es/es-revista-revista-argentina-anestesiologia-268- articulo-sindrome-takotsubo-a-proposito-un-S0370779217300340

  2. Lakdawala NK, Stevenson LW, Loscalzo J. Miocardiopatía y miocarditis. En: Jameson JL, Kasper DL, Longo DL, et al, editores. Harrison principios de medicina interna. Vol2. 20va ed. México: McGraw-Hill; 2018. p. 1779-1796.

  3. Sharkey SW. What Medicare Knows About the Takotsubo Cardiomyopathy. JAAC [internet]. 2016 [citado 22 enero 2020]; 4(3): 206-207. Disponible en: http://heartfailure.onlinejacc.org/content/4/3/206

  4. Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YA, et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): clinical characteristics, Diagnostic Criteria, and pathophysiology. ESC [internet]. 2018 [citado el 22 enero 2020]; 39: 2032-2046. Disponible en: https://academic.oup.com/eurheartj/article/39/22/2032/5025412

  5. Y-Hassan S, Tornvall P. Epidemiology, pathogenesis, and management of takotsubo syndrome. Clin Auton Res [Internet]. 2018 [citado 22 Ene 2020]; 28(1): 53–65. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805795/

  6. Núñez-Gil I.J, Mejía-Rentería H.D, Martínez-Losas P. Actualización práctica en síndrome de Takotsubo. Med Clin [Internet]. 2016 [citado el 22 Ene 2020]; 146 (5): e25-e30. Disponible en: https://www.elsevier.es/es-revista-medicina-clinica-2-articulo-actualizacion-practica-sindrome-takotsubo- S0025775315003218

  7. Akashi Y.J, Nef H.M, Lyon A.R. Epidemiology and pathophysiology of Takotsubo. Nat. Rev. Cardiol [Internet]. 2015 [citado 22 Ene 2020]; 12: 387-397. Disponible en: https://www.nature.com/articles/nrcardio.2015.39

  8. De Chazal H.M, Del Buono M.G, Keyser-Marcus L, Ma L, Moeller F.G, Berrocal D et al. Stress Cardiomyopathy Diagnosis and Treatment. JACC [Internet]. 2018 [citado 26 Ene 2018]; 72: 1955-1971. Disponible en: http://www.onlinejacc.org/content/72/16/1955.abstract

  9. Pelliccia F, Kaski J.C, Crea F, Camici P.G. Pathophysiology of Takotsubo Syndrome. Circulation [Internet]. 2017 [citado 27 Ene 2020]; 135: 2426-2441. Disponible en: https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.116.027121

  10. Falk R.H, Hershberger R.E. Miocardiopatías dilatada, restrictiva e infiltrante. En: Mann D.L, Zipes D.P, Libby P, Bonow R.O, Tomaselli G.F, Braunwald E, editores. Braunwald tratado de cardiología. Vol 2. 11a ed. España: Elsevier; 2019. p.1580-1601.

  11. Morales-Hernández AE, Valencia-López R, Hernández-Salcedo DR, Domínguez-Estrada J. Síndrome de Takotsubo. Med Int Méx [internet] 2016[citado 22 enero 2020]; 32(4): 475-491. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2016/mim164m.pdf

  12. Kato K, Lyon AR, Ghadri JR, Templin C. Takotsubo Syndrome: aetiology, presentation and treatment. Heartjnl [internet] 2017 [citado 26 enero 2020]; 103: 1461-1469. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28839096

  13. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical Features and outcomes of Takotsubo (stress) Cardiomyopathy. N ENGL J MED [internet] 2015[citado 26 enero 2020];373:929-938. Disponible en:https://ezproxy.ucimed.com:2119/doi/full/10.1056/NEJMoa1406761

  14. Sánchez AM, Sennhauser S, Lozier M, Purow J. Marijuana use and risk of takotsubo cardiomyopathy. JACC [internet] 2019 [citado 26 enero 2020]; 73 (9):2711.http://www.onlinejacc.org/content/73/9_Supplement_1/2711

  15. Arandia-Guzmán J, Antezalana-Llaveta G, Zárate-Carillo A. Miocardiopatía inducida por estrés o síndrome de Takotsubo a proposito de un caso. Gac Med Bol [intenet] 2018; [citado 26 enero 2020]; 21(1): 71-74. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_abstract&pid=S1012- 29662018000100015&lng=es&nrm=iso

  16. Ghadri J-R, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YA, et al. International Expert Consensus Document on Takotsubo Syndrome (Part Il): Diagnostic workup, Outcome and Management. ESC [Internet]. 2018 [citado 26 Ene 2020]; 39: 2047-2062. Disponible en: https://academic.oup.com/eurheartj/article/39/22/2047/5025411

  17. Ghadri J.R, Kato K, Cammann V.L, Gili S, Jurisic S, Di Vece D et al. Long-Term prognosis of patientes with Takotsubo Syndrome. JAAC [Internet]. 2018 [citado el 23 enero 2020]; 72 (8): 874-882. Disponible en: http://www.onlinejacc.org/content/72/8/874?




2020     |     www.medigraphic.com